argenx SE (ARGX)
1053.46
-1.91
(-0.18%)
USD |
NASDAQ |
Sep 03, 16:00
1049.18
-4.28
(-0.41%)
Pre-Market: 09:16
argenx Net Income (Annual) : 1.296B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.296B |
| December 31, 2024 | 831.57M |
| December 31, 2023 | -295.51M |
| December 31, 2022 | -709.98M |
| December 31, 2021 | -407.63M |
| December 31, 2020 | -612.49M |
| December 31, 2019 | -182.40M |
| December 31, 2018 | -78.62M |
| Date | Value |
|---|---|
| December 31, 2017 | -31.67M |
| December 31, 2016 | -23.64M |
| December 31, 2015 | -16.98M |
| December 31, 2014 | -13.68M |
| December 31, 2013 | -8.140M |
| December 31, 2012 | -12.46M |
| December 31, 2011 | -4.819M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Autolus Therapeutics Plc | -288.20M |
| Akari Therapeutics Plc | -17.34M |
| Forte Biosciences, Inc. | -69.38M |
| Evaxion AS | -7.731M |
| DBV Technologies SA | -147.40M |